BSE filing, NSE: VENLONPOLY. Summary written from the filing by ALFA Finder's alert engine.
Venlon Enterprises Ltd: key numbers
- Share price
- ₹3.66
- Market cap
- ₹19.12 Cr
- Revenue (annual)
- ₹7.94 Cr
- Net profit (annual)
- ₹-3.38 Cr
- P/E (TTM)
- -7.4×Sector 34.1×
- Promoter holding
- 60.38%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venlon Enterprises Ltd
All →Venlon Enterprises Other Announcement
Venlon Enterprises Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory filing.
Venlon Enterprises Annual General Meeting
Venlon Enterprises held its 42nd Annual General Meeting on September 18, 2026. The company transacted the business as mentioned in the AGM notice.
Venlon Enterprises Management Change
Venlon Enterprises Ltd has appointed Mr. Santhosh Kumar Shet as an Additional Non-Executive Independent Director, effective 18th September 2026.
Venlon Enterprises Annual General Meeting
Venlon Enterprises Ltd will convene its 42nd Annual General Meeting on September 18, 2026, at its registered office to approve financials and specific related party transactions.
Venlon Enterprises Q1 FY27 Results: Net Loss of ₹0.2 Cr, Loss Narrows
Venlon Enterprises Ltd reported revenue from operations of ₹1.1 Cr (-31.2% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Venlon Enterprises Board Meeting Date
Venlon Enterprises Limited has scheduled a board meeting for August 14, 2026, to consider and approve its standalone unaudited financial results for the quarter ending June 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.